a Department of Psychiatry & Behavioral Sciences , Women's Mood Disorders Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA.
b Department of of Gynecology & Obstetrics , Women's Mood Disorders Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA.
Int Rev Psychiatry. 2019 May;31(3):237-244. doi: 10.1080/09540261.2018.1553775. Epub 2019 Jan 31.
Psychiatric symptoms that coincide with reproductive transitions are related to changes in sex steroids, but studies show that this relationship is governed by individual women's vulnerability to change rather than by differences in level. There is growing interest in the role of allopregnanolone (ALLO), a 3- reduced metabolite of progesterone and a strong allosteric modulator of the GABA receptor, in such symptoms, with enough evidence now across various times of reproductive transition to offer an overview of the role of this hormone in reproductive psychiatry. This review offers a brief overview, focusing on literature of the last 3 years, of the relationship between allopregnanolone and mood at menarche; in the menstrual cycle; in the peripartum; and in the menopausal transition. ALLO dysregulation is identified in all of these transitions and found to be associated with mood symptoms, although evidence of its exact role; its relationship to other systems; and directionality is not consistent.
与生殖过渡期同时出现的精神症状与性激素的变化有关,但研究表明,这种关系受个体女性对变化的易感性的支配,而不是由水平差异决定。人们对同种妊娠素酮(ALLO)的作用越来越感兴趣,ALLO 是孕激素的 3-还原代谢产物,是 GABA 受体的强变构调节剂,在这些症状中,现在有足够的证据在各种生殖过渡期提供这种激素在生殖精神病学中的作用概述。这篇综述提供了一个简要概述,重点介绍了过去 3 年中同种妊娠素酮与月经初潮时情绪、月经周期、围产期和绝经过渡期之间关系的文献。在所有这些过渡中都发现同种妊娠素酮失调,并与情绪症状相关,尽管其确切作用、与其他系统的关系以及方向性的证据并不一致。